Currently, genetic approaches are preferred for testing individuals with MFS and Marfanoid habitus using a gene panel rather than single-gene analysis, followed by multiplex ligation-dependent probe amplification for negative samples because of the relevant number of mutations affecting genes other than FBN1 [29]. The gene discussed is FBN1; the disease is Marfan syndrome.